• Do you need definitive Human Milk Oligosaccharides (HMO) Market data?
• Succinct Human Milk Oligosaccharides (HMO) Market analysis?
• Clear competitor analysis?
• Actionable business recommendations?
In particular, Human Milk Oligosaccharides report concentrates on the following essential aspects of the Human Milk Oligosaccharides industry:
• Analysis of Key Players in Human Milk Oligosaccharides
• Inbiose NV
• Elicityl S.A.
• Jennewein Biotechnologie GmbH
• Glycom A/S
• Medolac Laboratories
• ZuChem Inc.
• Glycosyn LLC
• Gnubiotics Sciences Sarl
Global Human Milk Oligosaccharides (HMO) Market Outlook and Analysis from 2019-2029
• Human Milk Oligosaccharides (HMO) Market Forecasts and Analysis from 2019-2029 by Application
• Infant Formula Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Functional Food & Beverages Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Food Supplements Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Others Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Human Milk Oligosaccharides (HMO) Market Forecasts and Analysis from 2019-2029 by Product Type
• 2’FL Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• 3’FL Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• 3’SL Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• 6’SL Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Other Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Regional and Leading National Human Milk Oligosaccharides (HMO) Market Forecasts and Analysis from 2019-2029
• North America Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• US Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Canada Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Mexico Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Europe Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Germany Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• UK Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• France Human Milk Oligosaccharides (HMO) Forecast 2019 – 2029
• Italy Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Russia Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Rest of Europe Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Asia-Pacific Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• China Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Japan Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• India Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Rest of Asia-Pacific Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Latin America Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Brazil Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Rest of Latin America Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• MEA Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Israel Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Saudi Arabia Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• South Africa Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• UAE Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Rest of MEA Human Milk Oligosaccharides (HMO) Forecast 2019-2029
The Global Human Milk Oligosaccharides (HMO) Market 2019-2029 examines the Human Milk Oligosaccharides (HMO) Market comprehensively, using unique primary and secondary research all available to you, now.
Exclusively, Visiongain have applied our in-house analytical techniques for financial forecasting and analysis of drivers and restraints. Now available to you this comprehensive market-based report with detailed analyses, forecasts and informed opinion is essential to your Human Milk Oligosaccharides (HMO) Market development.
Human Milk Oligosaccharides (HMO) differ from currently-marketed Human Milk Oligosaccharides (HMO)s. Visiongain predicts that Human Milk Oligosaccharides (HMO) will significantly expand at a very high rate, contributing to rapid revenue growth during the period 2019 to 2028.
Why you should buy this report:
• To receive a comprehensive analysis of the prospects for Human Milk Oligosaccharides (HMO)
• To receive forecasts of Human Milk Oligosaccharides (HMO) sales in leading country markets from 2019-2029, including China, Japan and India
• To determine the forces that influence the market for Human Milk Oligosaccharides (HMO): drivers, restraints, opportunities and threats
• To find out where the Human Milk Oligosaccharides (HMO) Market is heading – both technologically and commercially from 2019-2029
Why You Must Buy This Report:
This report features news, insights, the latest developments and an in-depth survey of the Human Milk Oligosaccharides, HMO Market with up-to-date analysis as well as tables, graphs and charts. This report is a vital addition to gaining an understanding of this market sector and will give your company ‘the edge’ on your competitors. You cannot afford to be without this latest report from Visiongain.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Global Human Milk Oligosaccharides (HMO) Market Overview
1.2 Global Human Milk Oligosaccharides (HMO) Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Secondary Research
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to the Human Milk Oligosaccharides (HMO) Market
2.1 Global Human Milk Oligosaccharides (HMO) Market Structure
2.2 Human Milk Oligosaccharides (HMO) Market Definition
2.3 Human Milk Oligosaccharides (HMO) Market Supply Chain
3. Global Human Milk Oligosaccharides (HMO) Market 2019-2029
3.1 Global Human Milk Oligosaccharides (HMO) Market Forecast 2019-2029
3.2 Global Human Milk Oligosaccharides (HMO) Market Analysis
3.3 Global Human Milk Oligosaccharides (HMO) Market Drivers & Restraints 2019
4. Global Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029
4.1 Global Human Milk Oligosaccharides (HMO) Market Forecast by Antibiotics Segment 2019-2029
4.2 Global Human Milk Oligosaccharides (HMO) Market Forecast by 2’FL Segment 2019-2029
4.3 Global Human Milk Oligosaccharides (HMO) Market Forecast by 3’FL Segment 2019-2029
4.4 Global Human Milk Oligosaccharides (HMO) Market Forecast by 6’SL Segment 2019-2029
5. Global Human Milk Oligosaccharides (HMO) Market Forecast by Application 2019-2029
5.1 Global Human Milk Oligosaccharides (HMO) Market Forecast by Functional Food & Beverage Segment 2019-2029
5.2 Global Human Milk Oligosaccharides (HMO) Market Forecast by Infant Formula Segment 2019-2029
5.3 Global Human Milk Oligosaccharides (HMO) Market Forecast by Food Supplements Segment 2019-2029
5.4 Global Human Milk Oligosaccharides (HMO) Market Forecast by Processed Food Segment 2019-2029
6. Regional and Leading National Human Milk Oligosaccharides (HMO) Market Forecasts 2019-2029
6.1 North American Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029
6.1.2 North America Human Milk Oligosaccharides (HMO) Market by Application 2019-2029
6.1.4 North America Human Milk Oligosaccharides (HMO) Market by Country 2019-2029
6.1.5 North American Human Milk Oligosaccharides (HMO) Market Analysis
6.2 Asia Pacific Human Milk Oligosaccharides (HMO) Market Forecast 2019-2029
6.2.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Market by Country 2019-2029
6.2.3 Asia Pacific Human Milk Oligosaccharides (HMO) Market Analysis
6.3 Europe Human Milk Oligosaccharides (HMO) Market Forecast 2019-2029
6.3.2 European Human Milk Oligosaccharides (HMO) Market by Country 2019-2029
6.3.3 European Human Milk Oligosaccharides (HMO) Market Analysis
6.4 Latin American Human Milk Oligosaccharides (HMO) Market Forecast 2019-2029
6.4.2 Latin America Human Milk Oligosaccharides (HMO) Market by Country 2019-2029
6.5 MEA Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029
6.5.2 MEA Human Milk Oligosaccharides (HMO) Market by Country 2019-2029
6.6 Regional Human Milk Oligosaccharides (HMO) Market Share Forecast 2019, 2024 and 2029
7. SWOT Analysis of the Human Milk Oligosaccharides (HMO) Market 2019-2029
8. Leading Companies in the Human Milk Oligosaccharides (HMO) Market 2019
8.1 Leading Human Milk Oligosaccharides (HMO) Companies 2019
8.2 Inbiose NV
8.2.1 Inbiose NV Human Milk Oligosaccharides (HMO) Selected Recent Key Developments 2014-2018
8.2.2 Inbiose NV Sales 2015-2018
8.2.3 Inbiose NV Net Income 2015-2018
8.2.4 Inbiose NV Business Divisions
8.2.5 Inbiose NV Human Milk Oligosaccharides (HMO) Market Products / Services
8.2.6 Inbiose NV Overview
8.2.7 Inbiose NV Financial Outlook
8.2.8 Inbiose NV SWOT Analysis
8.3 Elicityl S.A.
8.3.1 Elicityl S.A. Key Development
8.3.2 Elicityl S.A. Sales 2014-2018
8.3.3 Elicityl S.A. Net Income / Loss 2014-2018
8.3.4 Elicityl S.A. Organisational Structure
8.3.5 Elicityl S.A. Human Milk Oligosaccharides (HMO) Products / Services
8.3.6 Elicityl S.A. Overview
8.3.7 Elicityl S.A. Financial Outlook
8.3.8 Elicityl S.A. SWOT Analysis
8.4 Jennewein Biotechnologie GmbH
8.4.1 Jennewein Biotechnologie GmbH Human Milk Oligosaccharides (HMO) Key Developments 2014-2017
8.4.2 Jennewein Biotechnologie GmbH Sales 2014-2018
8.4.3 Jennewein Biotechnologie GmbH Net Income 2014-2018
8.4.4 Jennewein Biotechnologie GmbH Organisational Structure
8.4.5 Jennewein Biotechnologie GmbH Human Milk Oligosaccharides (HMO) Market Products / Services
8.4.6 Jennewein Biotechnologie GmbH Overview
8.4.7 Jennewein Biotechnologie GmbH Financial Outlook
8.4.8 Jennewein Biotechnologie GmbH SWOT Analysis
8.5 Glycom A/S
8.5.1 Glycom A/S Human Milk Oligosaccharides (HMO) Key Developments 2017-2018
8.5.2 Glycom A/S Sales 2014-2018
8.5.3 Glycom A/S Net Income 2014-2018
8.5.4 Glycom A/S Company Structure
8.5.5 Glycom A/S Human Milk Oligosaccharides (HMO) Market Products / Services
8.5.6 Glycom A/S Overview
8.5.7 Glycom A/S Financial Outlook
8.5.8 Glycom A/S SWOT Analysis
8.6 Medolac Laboratories
8.6.1 Medolac Laboratories Key Developments 2015-2018
8.6.2 Medolac Laboratories Sales 2015-2018
8.6.3 Medolac Laboratories Net Income 2015-2018
8.6.4 Medolac Laboratories Business Sectors
8.6.5 Medolac Laboratories Human Milk Oligosaccharides (HMO) Market Products / Services
8.6.6 Medolac Laboratories Overview
8.6.7 Medolac Laboratories Financial Outlook
8.6.8 Medolac Laboratories SWOT Analysis
8.7 ZuChem Inc.
8.7.1 ZuChem Inc. Key Developments 2015-2018
8.7.2 ZuChem Inc. Human Milk Oligosaccharides (HMO) Market Products / Services
8.7.3 ZuChem Inc. Financial Outlook
8.8 Glycosyn LLC
8.8.1 Glycosyn LLC Key Developments 2016-2017
8.8.2 Glycosyn LLC Sales 2015-2018
8.8.3 Glycosyn LLC Company Structure
8.8.4 Glycosyn LLC Human Milk Oligosaccharides (HMO) Market Products / Services
8.8.5 Glycosyn LLC Overview.
8.8.6 Glycosyn LLC Financial Outlook
8.9 Gnubiotics Sciences Sarl
8.8.1 Gnubiotics Sciences Sarl Key Developments
8.8.2 Gnubiotics Sciences Sarl Sales 2014-2018
8.8.3 Gnubiotics Sciences Sarl Net Income / Loss 2014-2018
8.8.4 Gnubiotics Sciences Sarl Overview
8.8.5 Gnubiotics Sciences Sarl Financial Outlook
8.9 Other Leading Companies in the Value Chain
10. Conclusions
10.1 Key Research finding
10.2 Conclusion by Geography
10.2 Conclusion by Product Type
10.3 Conclusion by Application
10.4 Strategic Recommendations
11. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form
List of Figures
Figure 1.1 Global Human Milk Oligosaccharides (HMO) Market Segmentation
Figure 2.1 Global Human Milk Oligosaccharides (HMO) Market Segmentation Overview
Figure 2.2 Global Human Milk Oligosaccharides (HMO) Market Supply Chain
Figure 3.1 Global Human Milk Oligosaccharides (HMO) Market Forecast 2019-2029 (US$m, AGR %)
Figure 4.1 Global Human Milk Oligosaccharides (HMO) Market Share Forecast by Product Type 2019, 2024, 2029 (% Share)
Figure 4.2 Global Human Milk Oligosaccharides (HMO) Market Forecast for the Antibiotics Segment by Region 2019, 2024, 2029 (% Share)
Figure 4.3 Global Human Milk Oligosaccharides (HMO) Market Forecast for the 2’FL Segment by Region 2019, 2024, 2029 (% Share)
Figure 4.4 Global Human Milk Oligosaccharides (HMO) Market Forecast for the 3’FL Segment by Region 2019, 2024, 2029 (% Share)
Figure 5.2 Global Human Milk Oligosaccharides (HMO) Market Share Forecast for 3’FL Segment by Region 2019, 2024, 2029 (% Share)
Figure 5.3 Global Human Milk Oligosaccharides (HMO) Market Share Forecast for 3’SL Segment by Region 2019, 2024, 2029 (% Share)
Figure 5.4 Global Human Milk Oligosaccharides (HMO) Market Share Forecast for Feed Acidifiers Segment by Region 2019, 2024, 2029 (% Share)
Figure 5.5 Global Human Milk Oligosaccharides (HMO) Market Share Forecast for Others Segment by Region 2019-2024-2029 (%)
Figure 6.1 Regional Human Milk Oligosaccharides (HMO) Market Forecast 2019-2029 (US$m, AGR%)
Figure 6.2 North American Human Milk Oligosaccharides (HMO) Market Share Forecast by Product Type 2019, 2024, 2029 (% Share)
Figure 6.3 North American Human Milk Oligosaccharides (HMO) Market Forecast 2019-2029 (US$m, AGR%)
Figure 6.6 North America Human Milk Oligosaccharides (HMO) Market Share Forecast by Country 2019, 2024, 2029 (% Share)
Figure 6.7 North America Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.8 US Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.9 Canada Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.10 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Share Forecast by Product Type 2019, 2024, 2029 (% Share)
Figure 6.11 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$m, AGR%)
Figure 6.14 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Share Forecast by Country 2019, 2024, 2029 (% Share)
Figure 6.15 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.16 China Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.17 India Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.18 Japan Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.19 Europe Human Milk Oligosaccharides (HMO) Market Share Forecast by Product Type 2019, 2024, 2029 (% Share)
Figure 6.20 European Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$m, AGR%)
Figure 6.23 European Human Milk Oligosaccharides (HMO) Market Share Forecast by Country 2019, 2024, 2029 (% Share)
Figure 6.24 European Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.25 Germany Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.26 UK Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.27 France Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.28 Italy Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.29 Russia Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.30 Latin American Human Milk Oligosaccharides (HMO) Market Share Forecast 2019, 2024, 2029 (% Share)
Figure 6.31 Latin American Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$m, AGR%)
Figure 6.34 Latin America Human Milk Oligosaccharides (HMO) Market Share Forecast by Country 2019, 2024, 2029 (% Share)
Figure 6.35 Latin America Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.36 Brazil Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.37 MEA Human Milk Oligosaccharides (HMO) Market Share Forecast by Product Type 2019, 2024, 2029 (% Share)
Figure 6.38 MEA Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$m, AGR%)
Figure 6.41 MEA Human Milk Oligosaccharides (HMO) Market Share Forecast by Country 2019, 2024, 2029 (% Share)
Figure 6.42 MEA Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.43 Israel Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.44 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.45 South Africa Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.46 UAE Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.47 Rest of MEA Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.48 Regional Human Milk Oligosaccharides (HMO) Market Share Forecast 2019 (% Share)
Figure 6.49 Regional Human Milk Oligosaccharides (HMO) Market Share Forecast 2024 (% Share)
Figure 6.50 Regional Human Milk Oligosaccharides (HMO) Market Share Forecast 2029 (% Share)
Figure 8.1 Inbiose NV Sales 2015-2018 (US$m, AGR %)
Figure 8.2 Inbiose NV Net Income 2015-2018 (US$m, AGR %)
Figure 8.3 Inbiose NV Business Divisions 2017
Figure 8.4 Elicityl S.A. Sales 2014-2018 (US$m, AGR %)
Figure 8.5 Elicityl S.A. Net Income / Loss 2014-2018 (US$m)
Figure 8.6 Elicityl S.A. Organisational Structure 2017
Figure 8.7 Elicityl S.A. Segment Performance 2018 (%)
Figure 8.8 Jennewein Biotechnologie GmbH Sales 2014-2018 (US$m, AGR %)
Figure 8.9 Jennewein Biotechnologie GmbH Net Income 2014-2018 (US$m, AGR %)
Figure 8.10 Jennewein Biotechnologie GmbH Organisational Structure 2018
Figure 8.11 Glycom A/S Sales 2014-2018 (US$m, AGR %)
Figure 8.12 Glycom A/S Net Income 2014-2018 (US$m)
Figure 8.13 Glycom A/S Company Structure 2019
Figure 8.14 Medolac Laboratories Sales 2015-2018 (US$m, AGR %)
Figure 8.15 Medolac Laboratories Net Income 2015-2018 (US$m)
Figure 8.16 Medolac Laboratories Business Sectors 2018
Figure 8.17 Glycosyn LLC Sales 2015-2018 (US$m, AGR %)
Figure 8.18 Glycosyn LLC Company Structure 2018
Figure 8.19 Gnubiotics Sciences Sarl Sales 2013-2017 (US$m, AGR %)
Figure 8.20 Gnubiotics Sciences Sarl Net Income / Loss 2014-2018 (US$m)
Figure 8.21 Gnubiotics Sciences Sarl Segment Performance 2018 (%)
Figure 8.22 Agrana Beteiligungs-AG Sales 2013-2017 (US$m, AGR %)
Figure 8.23 Agrana Beteiligungs-AG Industry Group Revenue Share 2017 (%)
Figure 8.24 Agrana Beteiligungs-AG Products Segment Information 2018
List of Tables
Table 3.1 Global Human Milk Oligosaccharides (HMO) Market Forecast 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 4.1 Global Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 4.2 Global Human Milk Oligosaccharides (HMO) Market Forecast for the Antibiotics Segment by Region 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 4.3 Global Human Milk Oligosaccharides (HMO) Market Forecast for the 2’FL Segment by Region 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 4.4 Global Human Milk Oligosaccharides (HMO) Market Forecast for the 3’FL Segment by Region 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 5.2 Global Human Milk Oligosaccharides (HMO) Market Forecast for 3’FL Segment by Region 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 5.3 Global Human Milk Oligosaccharides (HMO) Forecast for the 3’SL Segment by Region 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 5.4 Global Human Milk Oligosaccharides (HMO) Market Forecast for Feed Acidifiers Segment by Region 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 5.5 Global Human Milk Oligosaccharides (HMO) Market Forecast for Others Segment by Region 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.1 Regional Human Milk Oligosaccharides (HMO) Market Forecast 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.2 North American Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.4 North America Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.5 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.7 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.8 Europe Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.10 European Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.11 Latin American Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.13 Latin America Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.14 MEA Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 7.1 Global Human Milk Oligosaccharides (HMO) Market SWOT Analysis 2019-2029
Table 8.1 Leading Human Milk Oligosaccharides (HMO) Companies 2019 (S.No., Company Name)
Table 8.2 Inbiose NV Profile 2019 (CEO, Parent Company Sales US$m, Net Income, Business Segment in the Market, HQ, Founded, No. of Employees, Website)
Table 8.3 Inbiose NV Key Developments 2014-2018 (Date, Strategy, Details)
Table 8.4 Inbiose NV Sales 2015-2018 (US$m, AGR %)
Table 8.5 Inbiose NV Net Income 2015-2018 (US$m, AGR %)
Table 8.6 Inbiose NV Human Milk Oligosaccharides (HMO) Market Products/Services (Segment of Business, Product, Specification / Features)
Table 8.7 Inbiose NV SWOT Analysis 2018
Table 8.8 Elicityl S.A. Profile 2019 (CEO, Parent Company Sales US$m, Net Income, Business Segment in the Market, HQ, Founded, No. of employees, Website)
Table 8.9 Elicityl S.A. Key Development (Date, Strategy, Details)
Table 8.10 Elicityl S.A. Sales 2014-2018 (US$m, AGR %)
Table 8.11 Elicityl S.A. Net Income / Loss 2014-2018 (US$MN)
Table 8.12 Elicityl S.A. Human Milk Oligosaccharides (HMO) Products/Services (Segment of Business, Product, Specification/ Features)
Table 8.13 Elicityl S.A. SWOT Analysis 2018
Table 8.14 Jennewein Biotechnologie GmbH Profile 2019 (CEO, Parent Company Sales US$m, Net Income, Business Segment in the Market, HQ, Founded, Website)
Table 8.15 Jennewein Biotechnologie GmbH Key Developments (Date, Strategy, Details)
Table 8.16 Jennewein Biotechnologie GmbH Sales 2014-2018 (US$m, AGR %)
Table 8.17 Jennewein Biotechnologie GmbH Net Income 2014-2018 (US$m, AGR %)
Table 8.18 Jennewein Biotechnologie GmbH Human Milk Oligosaccharides (HMO) Market Products / Services (Segment of Business, Product, Specification / Features)
Table 8.19 Jennewein Biotechnologie GmbH SWOT Analysis 2018
Table 8.20 Glycom A/S Profile 2019 (CEO, Parent Company Sales US$m, Net Income, HQ, Founded, No. of Employees, Website)
Table 8.21 Glycom A/S Key Developments 2017-2018 (Date, Strategy, Details)
Table 8.22 Glycom A/S Sales 2014-2018 (US$m, AGR %)
Table 8.23 Glycom A/S Net Income 2014-2018 (US$m)
Table 8.24 Glycom A/S Human Milk Oligosaccharides (HMO) Market Products/Services (Segment of Business, Product, Specification / Features)
Table 8.25 Glycom A/S SWOT Analysis 2018
Table 8.26 Medolac Laboratories Profile 2019 (CEO, Parent Company Sales US$m, Business Segment in the Market, HQ, Founded, No. of Employees, Website)
Table 8.27 Selected Recent Medolac Laboratories Human Milk Oligosaccharides (HMO) Market Developments 2015-2018 (Date, Strategy, Details)
Table 8.28 Medolac Laboratories Sales 2015-2018 (US$m, AGR %)
Table 8.29 Medolac Laboratories Net Income 2015-2018 (US$m, AGR %)
Table 8.30 Medolac Laboratories Human Milk Oligosaccharides (HMO) Market Products / Services (Segment of Business, Product, Specification / Features)
Table 8.31 Medolac Laboratories SWOT Analysis 2018
Table 8.32 ZuChem Inc. Profile 2019 (CEO, Parent Company Sales US$m, Business Segment in the Market, HQ, Founded, No. of Employees, Website)
Table 8.33 Selected Recent ZuChem Inc. Human Milk Oligosaccharides (HMO) Market Developments 2015-2018 (Date, Strategy, Details)
Table 8.34 ZuChem Inc. Human Milk Oligosaccharides (HMO) Market Products / Services (Segment of Business, Product, Specification / Features)
Table 8.35 Glycosyn LLC Profile 2019 (CEO, Parent Company Sales US$m, Business Segment in the Market, HQ, Founded, No. of Employees, Website)
Table 8.36 Selected Recent Glycosyn LLC Human Milk Oligosaccharides (HMO) Market Developments 2016-2017 (Date, Strategy, Details)
Table 8.37 Glycosyn LLC Sales 2015-2018 (US$m, AGR %)
Table 8.38 Glycosyn LLC Human Milk Oligosaccharides (HMO) Market Products / Services (Segment of Business, Product)
Table 8.39 Gnubiotics Sciences Sarl Profile 2019 (CEO, Parent Company Sales US$m, Net Income, Business Segment in the Market, HQ, Founded, No. of employees, Website)
Table 8.40 Gnubiotics Sciences Sarl Key Developments (Date, Strategy, Details)
Table 8.41 Gnubiotics Sciences Sarl Sales 2014-2018 (US$m, AGR %)
Table 8.42 Gnubiotics Sciences Sarl Net Income / Loss 2014-2018 (US$ MN)
Table 8.43 Agrana Beteiligungs-AG Profile 2019 (CEO, Parent Company Sales US$m, Industry Group in the Market, HQ, No. of Employees, Website)
Table 8.44 Selected Recent Agrana Beteiligungs-AG Human Milk Oligosaccharides (HMO) Market Developments 2016-2018 (Date, Strategy, Details)
Table 8.45 Agrana Beteiligungs-AG Sales 2013-2017 (US$m, AGR %)
Table 8.46 Agrana Beteiligungs-AG Industry Group Revenue 2017 (US$Mn)
Table 8.47 Agrana Beteiligungs-AG Human Milk Oligosaccharides (HMO) Market Products / Services (Segment of Business, Product, Specification / Features)
Table 8.48 Agrana Beteiligungs-AG Top Ten Markets in target Product Types (Rank, Countries)
Table 8.49 Agrana Beteiligungs-AG Top Ten Markets in Processing Solutions (Rank, Countries)
Table 8.50 Agrana Beteiligungs-AG SWOT Analysis 2018
Table 8.51 Other Leading Companies in the Human Milk Oligosaccharides (HMO) Market Value Chain 2018 (S. No, Company)
Table 8.1 Global Human Milk Oligosaccharides (HMO) Market Summary 2019, 2024, 2029 ($m, CAGR%)
Table 8.2 Global Human Milk Oligosaccharides (HMO) Market Summary by Geography (2019)
Table 8.4 Global Human Milk Oligosaccharides (HMO) Market Summary by Product Type (2019, 2029)
Visiongain Food & Drink
Visiongain Food & Drink
Visiongain Food & Drink
